Agios completes Phase 3 trial enrollment for Mitapivat in Sickle Cell Disease; reports $1.1 billion in payments post-FDA approval of Vorasidenib.
Read more
Anavex's Blarcamesine shows significant efficacy in Phase IIb/III trial for Alzheimer's Disease, slowing clinical progression by 36.3%.
Read more
PredicineCAREā¢ liquid biopsy aids FDA approval of Inavolisib for PIK3CA-mutated Breast Neoplasms.
Read more
David Deamer awarded ABRF honor for pioneering nanopore sequencing technology in biomolecular engineering.
Read more
Global drug discovery technologies market to grow at 12% CAGR, reaching $197 billion by 2029.
Read more
Vir Biotechnology advances hepatitis and oncology programs, reports Q3 2024 financials, and appoints new CFO.
Read more
Diadem's p53-specific antibody shows promise for early Alzheimer's Disease detection at CTAD 2024.
Read more
BPGbio's BPM31510T receives FDA Rare Pediatric Disease Designation for Epidermolysis Bullosa treatment.
Read more
Ring Therapeutics partners with A*STAR and SERI to advance gene therapy R&D in Singapore for Ophthalmology and Oncology.
Read more
Damona Pharmaceuticals receives FDA clearance for Phase 1 trial of DPX-101 targeting cognitive deficits in Major Depressive Disorder.
Read more
Boston Scientific to acquire Cortex, enhancing atrial fibrillation treatment with advanced cardiac mapping technology.
Read more
OSE Immunotherapeutics' Lusvertikimab shows significant efficacy in Phase 2 trial for Ulcerative Colitis.
Read more
Coloplast expands Executive Leadership Team to drive growth in Chronic Care, Voice & Respiratory Care, and Interventional Urology.
Read more
BlueWind Medical's Revi System shows comparable efficacy to sacral neuromodulation for Overactive Bladder and Urge Urinary Incontinence.
Read more
FDA accepts Ionis' NDA for donidalorsen, a potential prophylactic treatment for Hereditary Angioedema.
Read more
ENGULF trial shows HÄlo PE Thrombectomy System effective for Acute Pulmonary Embolism with significant clot burden reduction.
Read more
VenaSeal Spectrum trial finds cyanoacrylate closure superior to surgical stripping for venous disease with higher patient satisfaction.
Read more
VIVID trial confirms Duo Venous Stent System's safety and efficacy for iliofemoral venous obstruction over 24 months.
Read more
Intravascular fluid expansion significantly increases deep pelvic vein cross-sectional area, impacting venography results.
Read more
Biotia's AI-powered urine test receives NY State approval for advanced Urinary Tract Infections diagnostics.
Read more
FDA approves Journey Medical's Emrosi for treating Rosacea, showing superior efficacy in Phase 3 trials.
Read more
SOPHiA GENETICS promotes Ross Muken to President and appoints George Cardoza as Chief Financial Officer.
Read more
AbbVie partners with EvolveImmune to develop next-gen biotherapeutics for solid and hematologic malignancies.
Read more
FELIQS' FLQ-101 receives FDA Fast Track for Retinopathy of Prematurity, aiming to prevent childhood blindness.
Read more
AbbVie partners with EvolveImmune to develop next-gen multispecific antibodies for cancer treatment.
Read more
Alpha Cognition plans $25M financing and Nasdaq uplisting for Alzheimer's Disease drug development.
Read more
Evommune secures $115M to advance Phase 2 trials for chronic urticaria and atopic dermatitis treatments.
Read more
J INTS BIO launches AI alliance to enhance precision oncology for Lung Neoplasms.
Read more
